India Influenza Vaccine Market to Grow with a CAGR of 7.45% through 2030
Increasing
adoption of AI in radiology and pathology is expected to drive the India
Influenza Vaccine Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India Influenza Vaccine Market - By Region, Competition, Forecast & Opportunities, 2030F”, the India Influenza
Vaccine Market stood at USD 26.76 Million in 2024 and is anticipated to grow
with a CAGR of 7.45% through 2030. The rising public awareness about influenza
and its potential health risks has significantly boosted vaccination rates in
India, making it a key driver of the India Influenza Vaccine Market. Over the
past few years, increasing educational campaigns, government initiatives, and
media coverage have emphasized the importance of annual flu vaccinations,
especially for high-risk groups such as infants, elderly individuals, pregnant
women, and those with chronic respiratory conditions like asthma and COPD.
One of the major
contributors to this growing awareness is government-backed health programs
that actively promote flu vaccination. Initiatives such as the Universal
Immunization Programme (UIP) and Integrated Disease Surveillance Programme
(IDSP) have played a critical role in educating the population about the
seasonal nature of influenza and the need for timely immunization.
Additionally, the COVID-19 pandemic heightened public concern about respiratory
infections, leading to a surge in demand for flu vaccines as people became more
conscious of preventive healthcare measures.
Furthermore,
corporate healthcare programs and private hospitals have started flu
immunization drives, particularly in urban areas, ensuring that working
professionals and their families have easy access to vaccines. Social media,
television, and digital platforms have also become powerful tools in spreading
vaccine awareness, with healthcare professionals and influencers advocating for
annual flu shots to reduce severe illness and hospitalizations.
With rising
healthcare literacy, the Indian population is becoming more proactive in taking
preventive measures against influenza, increasing vaccine adoption across
different demographics. This heightened awareness, coupled with expanding
vaccine accessibility and affordability, continues to drive market growth,
ensuring higher immunization coverage and improved public health outcomes in
the country.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India Influenza Vaccine Market”
The India
Influenza Vaccine Market is segmented into type, indication, age group, route
of administration, distribution channel, regional distribution, and company.
Based
on Type, Inactivated have emerged as the fastest growing segment in the India
Influenza Vaccine Market in the forecast driven by its proven safety, broad
applicability, and strong immunogenic response. Unlike live attenuated
vaccines, inactivated influenza vaccines are suitable for all age groups,
including immunocompromised individuals, pregnant women, and elderly populations,
making them the preferred choice among healthcare providers. Government-backed
vaccination programs and corporate immunization drives have significantly
contributed to the segment’s rapid expansion. Additionally, increasing
awareness about seasonal flu prevention, coupled with the rising prevalence of
respiratory illnesses like asthma and COPD, has driven higher adoption of
inactivated vaccines. The availability of quadrivalent formulations within this
segment has further enhanced protection against multiple influenza strains,
strengthening its market dominance.
Based on Region,
North India have emerged as the fastest growing region in the India Influenza
Vaccine Market in 2024. This growth is
driven by increasing government immunization programs, rising public awareness
about influenza prevention, and expanding healthcare infrastructure in cities
like Delhi, Chandigarh, and Lucknow. The high
prevalence of respiratory illnesses due to severe winter conditions and
pollution levels, particularly in metropolitan and industrial areas, has
accelerated vaccine adoption. Additionally, government-led vaccination drives,
private healthcare initiatives, and corporate immunization programs have
further fueled demand. The region’s well-established distribution networks,
growing accessibility to advanced vaccines, and rising healthcare expenditure
contribute to its rapid market expansion, making North India the
fastest-growing region in the India Influenza Vaccine Market.
Major companies
operating in India Influenza Vaccine Market are:
- GSK PLC
- Pfizer
Inc
- Merck
& Co Inc
- Viatris
Inc
- AstraZeneca
PLC
- Sanofi
SA
- Serum
Institute of India
- Bharatbiotech
International Ltd
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Technological advancements in vaccine
formulation including the introduction of quadrivalent and needle-free nasal
vaccines—are reshaping the market landscape, fostering greater adoption and
compliance. The growing corporate focus on employee health programs and expanding
distribution networks in Tier 2 and Tier 3 cities further underscore the
market’s dynamic trajectory. As India strengthens its position in vaccine
research and manufacturing, the market is set for sustained expansion, driven
by innovation, strategic collaborations, and evolving consumer health
priorities”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“India Influenza Vaccine
Market By Type (Inactivated, Live Attenuated), By Indication (Quadrivalent,
Trivalent), By Age Group (Pediatric, Adult), By Route of Administration
(Injection, Nasal Spray), By Distribution Channel (Hospitals & Pharmacies,
Government & Institutional Supply, Other) By Region, Competition,
Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of India Influenza Vaccine Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Influenza Vaccine Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com